Perceval Sutureless Heart Valve
Corcym S.r.l. · Decision date Dec 22, 2025
What did the FDA decide?
FDA records P150011/S035 as a supplement to PMA P150011, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 22, 2025.
FDA approval order statement
a modification to the parameters used to laser cut the Perceval Plus pericardial patches
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 22, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150011/S035
- Regulatory pathway
- PMA supplement
- Applicant
- Corcym S.r.l.
- Product code
- LWR
- Decision code
- OK30
- Decision date
- Dec 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Corcym S.r.l.
- Product code
- LWR
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P150011/S033 · Related supplement
PERCEVAL SUTURELESS HEART VALVE
P150011/S034 · Related supplement
Perceval Sutureless Heart Valve
P150011/S035 received
Application receipt date recorded by FDA.
P150011/S035 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P150011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PERCEVAL SUTURELESS HEART VALVEP150011/S033 | Corcym S.r.l. | PMA supplement | Oct 28, 2025 | FDA |
Perceval Sutureless Heart ValveP150011/S034 | Corcym S.r.l. | PMA supplement | Oct 28, 2025 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Corcym S.r.l.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Via Crescentino Sn, Saluggia, 13040
Sources and methodology
- Original FDA record: P150011/S035
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records